The CBD sector is among the fastest-growing subcategories of consumer natural health products and for good reason. A recent report estimates that last year, the international consumer health CBD market was worth more than $9 billion, with an expected compound annual growth rate of nearly 25% in the period between 2020–2027.
Studies linking health and wellness to CBD have also driven the manufacture of products derived from CBD in industries such as food and beverages, nutraceuticals, personal care and cosmetics and pharmaceuticals, for health and wellness purposes.
Verdant Oasis VP Carl Germano states that new research which sheds light on the role of hemp phytocannabinoids such as CBD in supporting the endocannabinoid system will influence medicine and nutrition significantly.
Phytocannabinoids are cannabinoids that occur naturally in the marijuana plant. Thus far, researchers have identified more than 120 terpenes and 100 cannabinoids.
Below are some of the uses of CBD and other phytocannabinoids in wellness applications.
Research has found that CB1 and CB2, which are cannabinoid receptors, are found in hair follicles, eccrine sweat glands, melanocytes, dermal cells, cutaneous nerve fibers and epidermal keratinocytes. A study that administered CBD to cultured human sebocytes found that CBD could be used as a therapeutic agent for treating acne vulgaris because of its combined anti-inflammatory, anti-proliferative and lipostatic effects.
Dr. Jacknin’s Skincare CEO Jeanette Jacknin asserted that research had shown that topical CBD as well as other cannabinoids could help in wounds, eczema and acne and suggested that cannabinoids may also help with itching.
A recent review that centered on anxiety disorders and CBD found that CBD held significant potential as a treatment for multiple anxiety disorders. CBD also demonstrated effectiveness in decreasing anxiety in social anxiety disorder.
In a modeling study that simulated symptoms of acute respiratory distress syndrome, treatment using CBD reversed symptoms by increasing the quantity of a peptide known as apelin, which plays a crucial role in the peripheral and central regulation of immunity.
Another study found that cannabidiol could alleviate the uncontrolled cytokine production responsible for damaging lung tissue, in addition to launching numerous anti-inflammatory and immunomodulatory effects.
There is increasing evidence that suggests that phytocannabinoids have a positive effect on the musculoskeletal system. Research has found that CB1 and CB2 receptors, which can be found in bones, help to regulate bone maintenance. In animal studies, researchers have discovered that CBD can protect against bone loss and improve the healing of bone tissue.
With more interest and funds being directed to cannabinoid research to discover the therapeutic benefits they deliver, the CBD market is expected to grow significantly in the future.
As more becomes known about the benefits of phytocannabinoids, companies that make cannabinoid supplements and supplements, such as BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), are likely to benefit.
NOTE TO INVESTORS: The latest news and updates relating to BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) are available in the company’s newsroom at http://cnw.fm/BVNNF
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Do you have questions or are you interested in working with CNW420? Ask our Editor
CNW420 is part of the InvestorBrandNetwork.